COMPOSITIONS PHARMACEUTIQUES CONTENANT LA 2-METHYL-THIAZOLO-(4, 5-C) QUINOLEINE ET LEUR PROCEDE DE PREPARATION

COMPOSITIONS PHARMACEUTIQUES CONTENANT LA 2-METHYL-THIAZOLO-(4, 5-C) QUINOLEINE ET LEUR PROCEDE DE PREPARATION

LA PRESENTE INVENTION EST RELATIVE A DES COMPOSITIONS PHARMACEUTIQUES CONTENANT LA 2-METHYL-THIAZOLO4,5-C-QUINOLEINE DE FORMULE 1 :(CF DESSIN DANS BOPI)MEDICAMENTS MANIFESTANT UN EFFET DEPRESSEUR SUR LE SYSTEME NERVEUX CENTRAL. It has been found that 2-methyl-thiazolo[4,5-c]quinoline and pharmaceuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: JOZSEF KNOLL, BERENYI NEE EDIT POLDERMANN, BUDAI NEE KATALIN SIMONYI, BERTA KNOLL, ZSUZSA FURTS, JULIA TIMAR, GABRIELLA ZSILA, ILDIKO NIKLYA, LUJZA PETOCZ ET ATTILA MANDI
Format: Patent
Sprache:fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:LA PRESENTE INVENTION EST RELATIVE A DES COMPOSITIONS PHARMACEUTIQUES CONTENANT LA 2-METHYL-THIAZOLO4,5-C-QUINOLEINE DE FORMULE 1 :(CF DESSIN DANS BOPI)MEDICAMENTS MANIFESTANT UN EFFET DEPRESSEUR SUR LE SYSTEME NERVEUX CENTRAL. It has been found that 2-methyl-thiazolo[4,5-c]quinoline and pharmaceutically acceptable acid addition salts and hydrates thereof possess valuable central nervous depressive properties being different from those of benzodiazepines. The invention relates to pharmaceutical compositions comprising as active ingredient 2-methyl-thiazolo[4,5-c]quinoline of the Formula I (I) or a pharmaceutically acceptable acid addition salt or hydrate thereof.